Amphastar Pharmaceuticals (AMPH) Revenue (2016 - 2025)
Historic Revenue for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $191.8 million.
- Amphastar Pharmaceuticals' Revenue rose 32.74% to $191.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $723.3 million, marking a year-over-year decrease of 3.37%. This contributed to the annual value of $732.0 million for FY2024, which is 1358.98% up from last year.
- As of Q3 2025, Amphastar Pharmaceuticals' Revenue stood at $191.8 million, which was up 32.74% from $174.4 million recorded in Q2 2025.
- Amphastar Pharmaceuticals' 5-year Revenue high stood at $191.8 million for Q3 2025, and its period low was $101.7 million during Q2 2021.
- In the last 5 years, Amphastar Pharmaceuticals' Revenue had a median value of $145.7 million in 2023 and averaged $150.0 million.
- Per our database at Business Quant, Amphastar Pharmaceuticals' Revenue surged by 5030.18% in 2023 and then plummeted by 437.51% in 2025.
- Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Revenue stood at $120.9 million in 2021, then increased by 11.69% to $135.0 million in 2022, then surged by 31.91% to $178.1 million in 2023, then rose by 4.73% to $186.5 million in 2024, then grew by 2.85% to $191.8 million in 2025.
- Its Revenue was $191.8 million in Q3 2025, compared to $174.4 million in Q2 2025 and $170.5 million in Q1 2025.